Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Syntacoll GmbH specializes in advanced collagen-based biologic products and serves as a contract development and manufacturing organization (CDMO) with expertise in wound healing, infection prevention, and tissue engineering. It is an active subsidiary of Innocoll, manufacturing the commercial COLLATAMP G gentamicin-collagen sponge and supporting clinical supply for Innocoll's pipeline, including XaraColl (Phase 3 for post-operative pain). The company's CollaRx platform underpins its portfolio, with broad academic and industry partnerships and global reach.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Syntacoll.